CHRISTINA MESSINGER: Open Payments
NPI 1336717305 · PLYMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,532 in 149 payments from 18 companies in 2025. Trend: 2023 $2,751 · 2024 $4,470 · 2025 $2,532
Food & beverage: $2,414Education: $118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $523 |
| Janssen Biotech, Inc. | 17 | $393 |
| UCB, Inc. | 10 | $338 |
| Regeneron Healthcare Solutions, Inc. | 16 | $271 |
| Botanix SB Inc | 7 | $194 |
| Novartis Pharmaceuticals Corporation | 9 | $177 |
| E.R. Squibb & Sons, L.L.C. | 8 | $151 |
| Amgen Inc. | 2 | $77 |
| GENZYME CORPORATION | 3 | $77 |
| Galderma Laboratories, L.P. | 3 | $57 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, SOFDRA, Sotyktu, Rhapsido.
Industry payments across MA — which companies pay providers there.
